More importantly, we also found a much higher expression of CHTOP in human metastatic and malignant EOC tissues as compared to normal ovary tissues, adjacent tissues, or benign tumor tissues, suggesting that CHTOP might be a potential specific target for advanced ovarian cancer. This evidence concerns the gene CHTOP and benign neoplasm.